Status:
COMPLETED
Medico-economic Interest of the Protein S100b in Mild Head Trauma Under Anti-thrombotics
Lead Sponsor:
Rennes University Hospital
Collaborating Sponsors:
Roche Diagnostics GmbH
Conditions:
Mild Head Injury
Anticoagulant
Eligibility:
All Genders
18+ years
Brief Summary
Head trauma is a common injury in emergency department. Investigation to search for complication is guided by the clinical examination and the case history, such as taking anti-thrombotics. Cranial co...
Eligibility Criteria
Inclusion
- Patient ≥ 18 years old
- Taking antithrombotic medication (antiplatelet drugs, K vitamin antagonist, direct oral anticoagulants, heparins)
- Mild head trauma with Glasgow coma scale ≥ 13
- Trauma occured ≤ 6 hours
- Agreeing the participation in the study
Exclusion
- Head injury occured \> 6 hours
- Patient \< 18 years old or under juridic protection
- pregnant women
- polytrauma
- Glasgow coma scale ≤ 12
- ancient or actual cerebral ou cutaneous neoplasia
Key Trial Info
Start Date :
March 9 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 20 2021
Estimated Enrollment :
260 Patients enrolled
Trial Details
Trial ID
NCT04305821
Start Date
March 9 2020
End Date
September 20 2021
Last Update
April 12 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Universitaire de Rennes
Rennes, France, 35000